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identify changes in neuronal excitability
as a key mechanism mediating the
effects of sleep on Ab.
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Summary
Background: Emerging data suggest an important relation-
ship between sleep and Alzheimer’s disease (AD), but how
poor sleep promotes the development of AD remains unclear.
Results: Here, using a Drosophila model of AD, we provide
evidence suggesting that changes in neuronal excitability
underlie the effects of sleep loss on AD pathogenesis. b-amy-
loid (Ab) accumulation leads to reduced and fragmented
sleep, while chronic sleep deprivation increases Ab burden.
Moreover, enhancing sleep reduces Ab deposition. Increasing
neuronal excitability phenocopies the effects of reducing
sleep on Ab, and decreasing neuronal activity blocks the
elevated Ab accumulation induced by sleep deprivation. At
the single neuron level, we find that chronic sleep deprivation,
as well as Ab expression, enhances intrinsic neuronal excit-
ability. Importantly, these data reveal that sleep loss exacer-
bates Ab-induced hyperexcitability and suggest that defects
in specific K+ currents underlie the hyperexcitability caused
by sleep loss and Ab expression. Finally, we show that feeding
levetiracetam, an anti-epileptic medication, to Ab-expressing
flies suppresses neuronal excitability and significantly pro-
longs their lifespan.
Conclusions: Our findings directly link sleep loss to changes
in neuronal excitability and Ab accumulation and further sug-
gest that neuronal hyperexcitability is an important mediator
of Ab toxicity. Taken together, these data provide a mecha-
nistic framework for a positive feedback loop, whereby sleep
loss and neuronal excitation accelerate the accumulation of
Ab, a key pathogenic step in the development of AD.
Introduction
Alzheimer’s disease (AD) is the most common cause of de-
mentia worldwide, whose burden, both in terms of human
suffering and health care costs, is expected to rise sharply in
the next few decades [1]. b-amyloid (Ab) peptides, which are
generated from sequential cleavage of amyloid precursor pro-
tein (APP), have been strongly implicated as having a key role
in the pathogenesis of AD by substantial histopathologic,
biochemical, and genetic data [2]. Thus, there is intense
interest in identifying modifiable factors that modulate Ab.
Emerging evidence suggests potentially important links
between sleep and AD [3]. It has long been appreciated that
patients with AD have impaired sleep/wake cycles, with*Correspondence: marknwu@jhmi.edufragmented and reduced sleep at night [4–6]. Similarly, mouse
models of AD have been shown to exhibit reduced sleep dur-
ing their consolidated period [7, 8]. In humans, b-amyloid
deposition, as inferred by a decrease in Ab levels in cerebro-
spinal fluid (CSF), is associated with reduced sleep quality
[9], and reduced sleep and poor quality sleep are associated
with increased fibrillar Ab burden in the brain [10].
Intriguingly, recent data also support a bidirectional rela-
tionship between sleep and amyloid—i.e., not only may
Ab accumulation impair sleep, but poor sleep may increase
Ab burden [3]. In humans, consolidated sleep attenuates the
risk of developing AD conferred by the E4 allele of Apolipopro-
tein E (ApoE4, an important genetic polymorphism for AD)
[11, 12]. Moreover, a prospective study revealed that markedly
fragmented sleep, as measured by wrist actigraphy, increased
the risk of developing AD by w1.5-fold, compared to those
with the least fragmented sleep [13]. Importantly, using mouse
models of AD, Kang et al. (2009) demonstrated that chronic
sleep deprivation led to an increase in Ab burden in the brain.
What are the mechanisms by which sleep could modulate
Ab and thus impact AD? A recent study has suggested that
the ‘‘glymphatic system’’—a system of perivascular CSF chan-
nels and glial processes that serves to remove metabolic
waste from neurons in the brain—is more active during sleep
than in wake [14]. In this study, the authors also showed that
radioactively labeled Ab injected into the cortex was cleared
more efficiently during sleep, as compared to wakefulness.
Another potential mechanism underlying the relationship
between sleep and Ab is an alteration in neuronal activity.
Although the function of sleep remains enigmatic, one pro-
posed function of sleep is to downscale synaptic strength
following the synaptic potentiation that occurs duringwakeful-
ness [15]. For example, in rodents, molecular and electrophys-
iological markers of synaptic strength are increased following
wakefulness, as compared to following sleep [16]. Ab accumu-
lation also appears to be dependent on neuronal activity. For
example, Ab cleavage from APP is enhanced with increased
neural activity [17–19].
The fruit fly Drosophila melanogaster has been shown to
sleep [20–23] and has also been established as a model for
AD [24, 25]. There are several fly AD models, and we focused
on amodel that uses direct expression of human Ab42 coupled
to a signal peptide. Ab42-expressing flies have been shown to
recapitulate several key features of AD, including Ab deposi-
tion, age-dependent learning impairment, and neurodegene-
ration [26–28]. Here, using this model, we investigated the
functional interactions between sleep, excitability, and Ab.
Our findings support a bidirectional relationship between
sleep and Ab and argue that increased neuronal excitability
is a key mechanism underlying the effects of sleep on Ab.
Results
Ab Expression Leads to Reduced and Fragmented Sleep
To investigate the effects of Ab expression on sleep behavior
in Drosophila, we used an established model of AD, whereby
Ab40, Ab42, or AbArctic peptides are expressed pan-neuro-
nally [28]. Ab40 is less aggregate prone than Ab42, whereas
AbArctic carries a disease-causing mutation that leads to
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Figure 1. Induction of AbArctic Expression
Reduces and Fragments Sleep
(A) Sleep profile for da-GS>UAS-AbArctic flies
fed 250 mM RU486 (black squares, n = 92) or
vehicle control (gray diamonds, n = 77).
(B–E) Daytime sleep (B), nighttime sleep (C),
nighttime sleep bout number (D), and nighttime
sleep bout duration (E) for da-GS>Ab40 fed
RU486 (n = 48) or vehicle (n = 38), da-GS>Ab42
fed RU486 (n = 70) or vehicle (n = 36), and
da-GS>AbArctic fed RU486 or vehicle.
Data in (A) are from the same flies as in (B)–(E).
Error bars represent SEM; *p < 0.05, **p < 0.01,
***p < 0.001; ns, not significant.
703enhanced aggregation [28, 29]. In order to bypass develop-
mental effects, we induced expression of these Ab peptides
in all neurons during adulthood using daughterless-Genes-
witch (da-GS) [30]. We examined daytime and nighttime
sleep amount of da-GS>UAS-Ab40, da-GS>UAS-Ab42, and
da-GS>UAS-AbArctic flies and found that sleep amount was
not significantly affected with overexpression of Ab40 (Figures
1B and 1C). In contrast, nighttime sleep, but not daytime sleep,
was significantly reduced with overexpression of Ab42, while
both daytime sleep and nighttime sleep were significantly
decreased with overexpression of AbArctic (Figures 1A–1C).
These data suggest a ‘‘dose-dependent’’ relationship between
Ab aggregation and sleep amount. We next examined the
sleep architecture of these flies and found no significant effect
of expression of Ab40 and Ab42 on nighttime sleep bout
number or duration. However, inducing AbArctic expression
resulted in fragmentation of nighttime sleep, as evidenced by
an increase in sleep bout number and reduction in sleepbout duration during the night (Figures
1D and 1E). Consistent with these find-
ings, the sleep of AD patients has previ-
ously been reported to be fragmented at
night [5, 6]. Together, these data sug-
gest that, as is the case in humans and
mice, Ab expression in flies leads to
reduced and fragmented sleep.
Nighttime Sleep Deprivation
Increases Amyloid Burden
Previous work in mice has shown that
chronic lossof sleep leads toan increase
in Ab burden, raising the intriguing
possibility that poor sleep may promote
the pathogenesis of AD [31]. We thus
addressed whether this phenomenon
was conserved in other animals such
as fruit flies. To reduce the time needed
to visualize Ab deposits, we mainly
focused on UAS-AbArctic [28]. In addi-
tion, because one of the core features
of AD is memory loss [1] and the
mushroom bodies (MBs) in Drosophila
play a critical role in learning and mem-
ory [32], we expressed AbArctic pep-
tides in the Kenyon cells (KCs) of the
MBs using OK107-Gal4. Using mecha-
nical deprivation, we subjected OK107-Gal4>UAS-AbArctic flies to nighttime sleep deprivation for
1 week. As the use of chronic mechanical deprivation would
increase locomotor activity and potentially result in ‘‘physical
stress,’’ we also subjected flies to a similar deprivation
paradigm during the daytime, to control for this potential
confounder. As shown in Figures 2A and 2B, daytime sleep
deprivation effectively reduceddaytimesleepbut left nighttime
sleep relatively intact, whereas nighttime sleep deprivation
markedly reduced nighttime sleep and led to an increase in
daytime sleep, likely reflecting ‘‘rebound sleep.’’ As expected,
daily activity counts of OK107-Gal4>UAS-AbArctic subjected
to nighttime sleep deprivation were significantly increased,
compared to those of flies not subjected to mechanical depri-
vation.However, therewasnosignificant increase in locomotor
activity in these flies when compared to those undergoing
daytime sleep deprivation (Figure 2C). To assess Ab burden,
we immunostained the brains of these flies using 6E10,
a monoclonal antibody that detects an N-terminal epitope on
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control Figure 2. Mechanical Sleep Deprivation En-
hances Ab Burden
(A) Sleep profile for OK107-Gal4>UAS-AbArctic
flies undergoing no sleep deprivation, daytime
sleep deprivation, or nighttime sleep deprivation
from a representative experiment. White bars
and black bars denote light and dark periods,
respectively.
(B and C) Sleep amount (B) and daily activity (C)
for OK107-Gal4>UAS-AbArctic flies, where ‘‘2,’’
‘‘Day,’’ and ‘‘Night’’ denote no sleep deprivation,
daytime sleep deprivation, and nighttime sleep
deprivation, respectively.
(D) Representative whole-mount brain confocal
images for OK107-Gal4>UAS-AbArctic flies un-
dergoing daytime (‘‘day dep’’) or nighttime (‘‘night
dep’’) sleep deprivation, immunostained with
anti-Ab42 antibody (6E10). Maximum projection
images are shown.
(E) Normalized Ab signal intensity in the MB KCs
from OK107-Gal4>UAS-AbArctic flies undergo-
ing no sleep deprivation (n = 10), daytime sleep
deprivation (n = 10), or nighttime sleep depriva-
tion (n = 9).
Ab signal intensity is not normallydistributed and is
thus presented here and in subsequent figures as
a simplified boxplot, with the median shown as
the line inside theboxand the 75th and25thpercen-
tiles shown as the top and bottom, respectively.
Scale bar represents 100 mm. Error bars represent
SEM; *p < 0.05, ***p < 0.001; ns, not significant.
704the Ab42 peptide. Strikingly, confocal imaging of whole-mount
brains demonstrated a significant increase in Ab signal in
OK107-Gal4>UAS-AbArctic flies undergoing chronic nighttime
sleep deprivation, compared to no deprivation or daytime
sleep deprivation (Figures 2D and 2E). To reproduce these
findings with a different MB-expressing driver, we examined
MB247-LexA>LexAop-AbArctic flies [33] and obtained similar
results (Figure S1A). We asked whether these findings were
specific for theMBs and found that nighttime sleep deprivation
significantly increased AbArctic accumulation in two other
brain regions, the pars intercerebralis (using OK107-Gal4)
and antennal lobes (using NP1227-Gal4) (Figure S1A). To
examine whether these effects were specific to using UAS-
AbArctic, we repeated these experiments using UAS-Ab42.
As shown in Figures S1C–S1E, the effects of nighttime
and daytime sleep deprivation on sleep amount, daily activity,
and Ab burden were all recapitulated usingOK107-Gal4>UAS-
Ab42 flies. We next assessed whether mechanical sleep depri-
vation would increase accumulation of an unrelated protein.
As shown in Figure S1B, there was no increase in GFP signal
whenOK107-Gal4>UAS-GFP flies were subjected to nighttime
sleep deprivation. Finally, we asked whether other manipu-
lations that enhance cellular stress would affect AbArctic or
GFP accumulation. Neither chronic exposure to 31C nor
1 mM paraquat affected AbArctic or GFP burden in the MBKCs (Figure S1F). Together, these data
suggest that loss of nighttime sleep spe-
cifically leads to an increase inAbburden
in a fly model of AD.
Genetic Manipulation of Sleep
Modulates Amyloid Burden
To further investigate how changes in
sleep affect Ab accumulation, we usedgenetic approaches to reduce or increase sleep, instead of
mechanical deprivation. To do this, we used two binary
expression systems: the Gal4/UAS system to manipulate
neurons that regulate sleep and the LexA/LexAop system to
express AbArctic in the MBs. We previously demonstrated
that activation of a subset of dopaminergic (DAergic) neurons
using TH-D4-Gal4 significantly reduces sleep amount [34].
Thus, we used TH-D4-Gal4 to drive expression of dTrpA1, a
heat-inducible cation channel [35] to activate DA neurons in
flies expressing AbArctic in the MBs (MB247-LexA>LexAop-
AbArctic). As shown in Figure 3C, conditionally activating
this subset of DA neurons resulted in a significant decrease
in nighttime sleep, compared to controls. Similar to flies under-
going mechanical nighttime sleep deprivation, these flies ex-
hibited a significant increase in Ab accumulation, compared
to controls (Figures 3A and 3D). It was previously shown
that the ExFl2 fan-shaped body (FB) neurons promote sleep
[36, 37], and we recently identified a restricted Gal4 driver
(R72G06-Gal4) from the Rubin collection at Janelia Farm that
contains these cells (data not shown). Thus, in order to
address whether increasing sleep would cause the opposite
phenotype, i.e., a decrease in Ab burden, we generated
R72G06-Gal4>UAS-dTrpA1, MB247-LexA>LexAop-AbArctic
flies. As expected, conditional activation of FB neurons in
these flies resulted in an increase in daytime and nighttime
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Figure 3. Genetic Manipulation of Sleep Modu-
lates Ab Levels
(A and B) Representative maximum projection
images of whole-mount brains immunostained
with 6E10 fromLexAop-AbArctic/+;UAS-dTrpA1/
MB247-LexA (‘‘ctrl,’’ top panels) and LexAop-
AbArctic/+; UAS-dTrpA1/MB247-LexA, TH-D4-
Gal4 (‘‘TH-D4-Gal4>UAS-dTrpA1,’’ bottompanel),
and LexAop-AbArctic/+; UAS-dTrpA1/R72G06-
Gal4, MB247-LexA (‘‘ExFl2-Gal4>UAS-dTrpA1,’’
bottom panel) flies.
(C) Daytime and nighttime sleep amounts
for LexAop-AbArctic/+; UAS-dTrpA1/MB247-
LexA (n = 24), LexAop-AbArctic/+; UAS-dTrpA1/
MB247-LexA, TH-D4-Gal4 (n = 24), and LexAop-
AbArctic/+; UAS-dTrpA1/R72G06-Gal4, MB247-
LexA (n = 22).
(D) Normalized Ab signal intensity in the MB
KCs for the flies in (C), shown as a simplified
boxplot.
dTrpA1 was chronically activated by subject-
ing flies to 29C for 1 week. Scale bar repre-
sents 100 mm. Error bars represent SEM; *
p < 0.05, ***p < 0.001.
705sleep (Figure 3C). Importantly, genetically increasing sleep in
these flies decreased Ab burden (Figures 3B and 3D). These
data thus provide further evidence that sleep can modulate
Ab burden and suggest that enhancing sleep can reduce Ab
pathology.
Manipulation of Neuronal Excitability Alters Ab
Accumulation
Previous work suggests that sleep deprivation increases
neuronal excitability and synaptic transmission [15, 38]. We
thus investigated whether alterations in neuronal excitability
might underlie the changes in Ab burden that we observe with
manipulations of sleep. We first asked whether increasing
neuronal excitabilitywould result in an increase in Ab accumula-
tion. Expression of the bacterial sodium channel NaChBac [39]
in the MBs along with AbArctic (OK107-Gal4>UAS-NaChBac,
UAS-AbArctic) resulted in a significant increase in Ab signal in
the MBs (Figure S2B). However, this manipulation simulta-
neously reduced nighttime sleep in these flies (Figure S2A),
making it difficult to disentangle whether activating these cells
alone leads to an increase in Ab burden. Therefore, to further
assess this issue, we examined Ab levels in the ExFl2 FB neu-
rons in R72G06-Gal4>UAS-NaChBac, AbArctic flies. In flies ex-
pressing NaChBac and AbArctic simultaneously in these ExFl2
FBneurons, daytime sleepwas increased compared to controls
(Figure S2C), and a significant increase in Ab burden was
observed in the ExFl2 cells, compared to controls (Figure S2D).
These data thus dissociate changes in sleep from changes in
excitability and suggest that enhancing neuronal excitability
acts downstream of changes in sleep to increase Ab burden.To further address whether changes
in excitability act downstream of sleep
in modulating Ab, we asked whether
reducing neuronal excitability could
suppress the increase in Ab signal
seen with sleep deprivation. We used
dORKDC2, an outward rectifying potas-
sium channel [40], to decrease excit-
ability of MB KC neurons. As a control,we used the non-conducting version of this channel,
dORKDNC. Reducing neuronal excitability in MB KCs led to
a trend toward an increase in daytime sleep in animals not
undergoing sleep deprivation, while a marked reduction in
nighttime sleep was observed in all animals undergoing sleep
deprivation (Figure 4A). As shown in Figures 4B and 4C, elec-
trically inhibiting the MB KCs essentially blocked the increase
in Ab burden caused by sleep deprivation. These data suggest
that hyperexcitability is necessary for sleep deprivation-
dependent increases in Ab accumulation.
Sleep Deprivation Increases Intrinsic Neuronal Excitability
In order to investigate the functional relationship between
sleep, neuronal excitability, and Ab, we decided to examine
different neuronal cell groups. The circadian network in
Drosophila consists of w150 neurons comprised of different
cell groups with distinct patterns of neuronal activity [41, 42].
The lateral groups (the ventrolateral and dorsolateral) are
particularly suitable for the identification and imaging of
individual cells. In addition, the ventrolateral neurons can be
readily accessed for whole-cell patch-clamp recordings, and
the large ventrolateral neurons (l-LNvs) in particular have
been shown to play a role in sleep/wake regulation [43–48].
Thus, the l-LNvs can be used to examine the relationship
between sleep, neuronal activity, and Ab accumulation in a
single cell type. We used the cry-Gal4 driver to manipulate
the l-LNvs and the dorsolateral (LNd) groups (Figure 5A). We
first expressed AbArctic in these cells and investigated
whether chronic sleep deprivation increased Ab burden. As
shown in Figures 5B and 5C, nighttime sleep deprivation
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Figure 4. Inhibiting Neuronal Excitability Sup-
presses Ab Accumulation Induced by Sleep Loss
(A–F) Daytime and nighttime sleep amounts
(A), representative maximum projection images
of KCs from whole-mount brains immunostained
with 6E10 (B–E), and normalized Ab signal inten-
sity in the MB KC neurons (F) for OK107-
Gal4>UAS-AbArctic, UAS-dORKDNC without
sleep deprivation (n = 20) and with sleep depriva-
tion (n = 13) and OK107-Gal4>UAS-AbArctic,
UAS-dORKDC2without sleep deprivation (n = 17)
and with sleep deprivation (n = 13). Scale bar
represents 100 mm. Error bars represent SEM;
*p < 0.05, **p < 0.01, ***p < 0.001; ns, not
significant.
706caused an increase in Ab signal in l-LNv cells, compared to
controls, but not in LNd cells (which may reflect higher base-
line Ab expression in those cells; data not shown).
Our previous data suggest that changes in excitability
act downstream of alterations in sleep to modulate Ab levels.
Indeed, previous studies have suggested that sleep ‘‘down-
scales’’ synaptic strength and that consequently, sleep
deprivation leads to increased synaptic transmission [15].
Thus, we sought evidence that sleep deprivation could directly
affect neuronal excitability. To address this question, we
performed whole-cell patch-clamp recordings of l-LNvs from
animals with or without sleep deprivation and examined both
the spontaneous action potential (AP) firing rate and evoked
firing responses. As expected, nighttime sleep deprivation re-
sulted in a significant decrease in nighttime sleep (Figure S3C).
In order to isolate the l-LNv neurons from most excitatory and
inhibitory inputs, we performed these recordings in the pres-
ence of mecamylamine (50 mM) and picrotoxin (250 mM). As
shown in Figures 5D and 5E, the spontaneous AP firing rate
of the l-LNv neurons was significantly increased (w1.8-fold)
in flies subjected to sleep deprivation versus controls. Similar
data were also obtained from measuring evoked responses
from these neurons. Evoked AP firing rate was increased
at all measured depolarizing currents (Figure 5F), and thefrequency-current (f-I) slope was sig-
nificantly increased in sleep-deprived
animals, compared with controls (Fig-
ure 5G). We did not observe any sig-
nificant change in resting membrane
potential (RMP) in sleep-deprived ani-
mals versus controls (Figures S3A and
S3B). Together, these data suggest
that sleep deprivation enhances both
spontaneous and evoked measures of
intrinsic neuronal excitability.
Ab-Dependent Hyperexcitability Is
Exacerbated by Sleep Deprivation
Next, we examined whether Ab expres-
sion itself could also modulate neuronal
excitability. Work in mammals has been
conflicting, suggesting that Ab can
cause either a decrease or an increase
in neuronal excitability [49–51]. To
address this question in the Drosophila
brain, we performed whole-cell patch-
clamp recordings on the l-LNv neuronsin flies overexpressing Ab40, Ab42, or AbArctic using cry-
Gal4. As shown in Figure 6A, expression of AbArctic, but not
Ab40 or Ab42, led to a significant increase in spontaneous
AP firing rate compared to controls. We next examined evoked
parameters of excitability and found that overexpression
of AbArctic, but not Ab40 or Ab42, resulted in a significant
increase in intrinsic neuronal excitability. In particular, the
frequency of AP firing was increased in response to a range
of injected currents, and the f-I slope was similarly increased
(Figures 6B and 6C). RMP was not significantly affected in
any of these conditions (Figure S4A). Together, these data
suggest that AbArctic expression on its own can enhance
intrinsic neuronal excitability.
Given our previous finding that sleep deprivation alone
could cause neuronal hyperexcitability, we next asked
whether chronic sleep deprivation would further exacerbate
AbArctic-induced hyperexcitability. We examined cry-Gal4>
UAS-AbArctic flies subjected to chronic sleep deprivation
(Figure S4C) and found that these flies exhibited a further
increase in spontaneous and evoked intrinsic neuronal
excitability, compared to non-sleep-deprived cry-Gal4>UAS-
AbArctic as well as controls (Figures 6D–6G). RMP was depo-
larized, further suggesting that excitability was increased in
the presence of AbArctic with sleep deprivation (Figure S4B).
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Figure 5. Sleep Deprivation Increases Intrinsic Neuronal Excitability
(A) Maximum projection of a whole-mount brain immunostained with anti-GFP from cry-Gal4>UAS-CD8::GFP.
(B and C) Normalized Ab signal intensity in l-LNv (B) and LNd (C) cells for cry-Gal4>UAS-AbArcticwith (n = 24) or without (n = 21) sleep deprivation, shown as
a simplified boxplot.
(D) Representative traces showing spontaneous AP firing of l-LNvs at ZT0-3 in cry-Gal4>UAS-CD8::GFP flies with or without sleep deprivation (SD). The
bottom traces in (D) are expanded traces of the boxed regions in the top traces.
(E–G) Mean firing rate of spontaneous activity (E), mean frequency of spikes elicited in response to current injections with 300-ms stepping pulses at 20-pA
increments ranging from230 pA to 100 pA (F), and f-I slope (G) of l-LNv neurons in control (cry-Gal4>UAS-CD8::GFP) animals with (n = 12) or without (n = 15)
sleep deprivation.
Recordings were performed in the presence of mecamylamine (50 mM) and picrotoxin (250 mM) in order to isolate these cells frommost excitatory and inhib-
itory inputs. Scale bar represents 200 mm. Error bars represent SEM; *p < 0.05; ns, not significant.
707In summary, these data suggest that sleep deprivation exacer-
bates the intrinsic neuronal hyperexcitability induced by Ab
expression.
Sleep Deprivation and Ab Expression Lead to Impairment
of Specific K+ Channel Currents
Changes in excitability could reflect alterations in a variety of
ionic currents. Given that K+ channels in particular have beenimplicated in the regulation of sleep previously, we focused
on changes to K+ currents [52–57]. To identify possible mech-
anisms for the hyperexcitability observed in l-LNv cells
following chronic sleep deprivation (Figure S4D), we recorded
steady-state activation of three types of K+ currents: A-type
K+ current (IA), sustained K
+ current (IK(V)), and Ca
2+-activated
K+ currents (KCa) under voltage-clamp configuration. We
found that over a range of membrane potentials, all three
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Figure 6. Sleep Deprivation Exacerbates Ab-Dependent Neuronal Hyperexcitability
(A–C) Mean firing rate of spontaneous activity (A), mean frequency of spikes elicited in response to current injections ranging from 230 pA to 100 pA (B),
and f-I slope (C) of l-LNv neurons in control cry-Gal4>UAS-CD8::GFP (n = 16), cry-Gal4>UAS-Ab40, UAS-CD8::GFP (n = 17), cry-Gal4>UAS-Ab42,
UAS-CD8::GFP (n = 15), and cry-Gal4>UAS-AbArctic, UAS-CD8::GFP (n = 18).
(D) Representative traces showing AP firing of l-LNv neurons in control versus cry-Gal4>UAS-AbArctic, UAS-CD8::GFP flies 6 sleep deprivation (SD).
Bottom traces in (D) are expanded traces of the boxed regions in the top traces.
(E–G) Mean firing rate of spontaneous activity (E), mean frequency of spikes elicited in response to current injections ranging from 230 pA to 100 pA (F),
and f-I slope (G) of l-LNv neurons in control (n = 17) versus cry-Gal4>UAS-AbArctic, UAS-CD8::GFP with (n = 15) or without (n = 19) sleep deprivation.
(H–J) IA (H), IK(V) (I), and KCa (J) current amplitude at the spike threshold (230 mV) from l-LNvs for cry-Gal4>UAS-CD8::GFP with (n = 5, 10, and 11,
respectively) or without (n = 5, 7, and 8, respectively) sleep deprivation and cry-Gal4>UAS-AbArctic, UAS-CD8::GFP with sleep deprivation (n = 5, 6, and
4, respectively).
Recordings were performed in the presence of mecamylamine (50 mM) and picrotoxin (250 mM) in order to isolate these cells from most excitatory and
inhibitory inputs. Error bars represent SEM; *p < 0.05, **p < 0.01; ns, not significant.
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Figure 7. Levetiracetam Suppresses Neuronal
Firing and Prolongs Lifespan of AbArctic-
Expressing Flies
(A) Representative traces showing spontaneous
firing of l-LNv neurons in control (cry-Gal4>
UAS-CD8::GFP) versus cry-Gal4>UAS-AbArctic,
UAS-CD8::GFP flies fed vehicle or 5 mg/kg leve-
tiracetam (LEV).
(B) Quantification of mean firing rates shown
in (A) (n = 4 for control, n = 5 for AbArctic, and
n = 8 for AbArctic + LEV).
(C and D) Survivorship curves of elav-Gal4>UAS-
AbArctic female (C) and male (D) flies fed vehicle
or 5 mg/kg LEV.
(E) Lifespan extension of elav-Gal4>UAS-
AbArctic female andmale flies by LEV, where life-
span is displayed as a simplified boxplot. Data
for the elav-Gal4>UAS-AbArctic (‘‘Arctic’’) flies
shown here are the same as in (C) and (D) (n =
98 for vehicle-fed females and n = 52 for LEV-
fed females; and n = 100 for vehicle-fed males
and n = 60 for LEV-fed males). For elav-Gal4/+
(‘‘ctrl’’) flies, n = 30 for vehicle-fed and LEV-fed
females and males.
(F) Model connecting sleep, neuronal excitability,
and Ab. Sleep loss leads to a reduction in Ca2+-
dependent K+ currents, causing neuronal hyper-
excitability. This enhanced excitability, in turn,
results in increased Ab accumulation. Ab itself
reduces sleep and further increases neuronal
excitability via a decrease in voltage-gated K+
currents, generating a positive feedback loop
whereby sleep loss and Ab interact to substan-
tially increase neuronal activity and Ab burden.
Increased neuronal excitability then contributes
to reduced lifespan.
Error bars represent SEM; *p < 0.05, **p < 0.01,
***p < 0.001; ns, not significant.
709currents from sleep-deprived flies were significantly reduced
compared with non-deprived control flies (Figures S5A–S5C).
However, at a potential (230 mV) near the spike threshold,
only KCa currents showed a significant reduction compared
to non-sleep-deprived controls (Figures 6J and S5F). We
next subjected cry-Gal4>UAS-AbArctic flies to sleep depriva-
tion and found that, in addition to KCa currents, IA currents
became markedly reduced at potentials near the spike
threshold (Figures 6H and S5D). In sleep-deprived animals
with or without AbArctic expression, there was no significant
effect on IK(V) currents (Figures 6I and S5E). These data sug-
gest that alterations in KCa and IA currents may play a role in
the changes of excitability observed in l-LNv neurons under
conditions of sleep deprivation and AbArctic expression.
Levetiracetam Prolongs the Lifespan of Ab-Expressing
Animals
Our data point toward changes in neuronal excitability as a key
mediator of the effects of sleep loss on Ab deposition. Further-
more, Ab expression itself can induce neuronal hyperexcitabil-
ity. Interestingly, abnormal elevations in neuronal activity can
be seen in a variety of ‘‘pre-Alzheimer’’ states, including mild
cognitive impairment (MCI) and ApoE4 carrier status [58, 59].
Furthermore, recent studies in humans with MCI and an AD
mouse model have suggested that reducing neuronal excit-
ability using the anticonvulsant levetiracetam (LEV) improvesperformance in learning and memory tests [60, 61]. Therefore,
we wished to test the functional relevance of the hyperexcit-
ability observed in AbArctic-expressing flies by using LEV.
We first examined whether feeding LEV to AbArctic-express-
ing flies would suppress the increased AP firing rate seen in
their l-LNv neurons. As shown in Figures 7A and 7B, when
cry-Gal4>UAS-AbArctic flies were chronically fed LEV (5 mg/
kg) in their food, the increased AP firing rate of l-LNv neurons
was reduced back to control levels. Neuronal activity can be
associated with changes in neuronal structure [62], and the
LNv neurons have been shown to exhibit experience- and
sleep-dependent morphological changes [63, 64]. Therefore,
we asked whether AbArctic expression coupled with sleep
deprivation affected the synaptic morphology of these neu-
rons and whether LEV might suppress this effect. The LNv
neurons express the neuropeptide pigment dispersing factor
(PDF) and so we used anti-PDF to label the synaptic terminals
of these cells. Sleep-deprived flies expressing AbArctic in their
LNv neurons displayed a significant increase in PDF+puncta in
the optic lobes, and LEV treatment significantly inhibited this
effect (Figure S6A). However, given that PDF is a releasable
neuropeptide, we cannot rule out that these changes reflect
alterations in the production or release of PDF. We next asked
whether LEV treatment could inhibit the increase in Ab burden
in l-LNv neurons seen with sleep deprivation. As shown in Fig-
ure S6B, LEV treatment resulted in a trend toward suppression
710of the increased Ab burden induced by sleep deprivation,
although this effect was not statistically significant.
Finally, pan-neuronal expression of AbArctic peptide in flies
has previously been shown to reduce lifespan [28], so we
asked whether suppressing neuronal hyperactivity by feeding
these flies LEV would prolong their lifespan. We examined life-
span in elav-Gal4>UAS-AbArctic flies and found, as expected,
that these flies exhibited a reduction in their median lifespan,
when compared to elav-Gal4 controls (60 versus 45 days
for females and 61 versus 38 days for males) (Figure 7E).
Strikingly, when elav-Gal4>UAS-AbArctic flies were fed LEV
(5 mg/kg), their median lifespan was significantly extended
by w16% and w18% for females and males, respectively
(Figures 7C–7E). In contrast, LEV did not extend the lifespan
of control elav-Gal4/+ female or male flies, suggesting that
these effects are specific to AbArctic-expressing flies (Figures
S6C and S6D). Together, these data strongly suggest
that neuronal hyperexcitability is an important mediator of
Ab-induced toxicity.
Discussion
Our study supports a bidirectional relationship between sleep
and Ab and points toward an intimate relationship between
sleep, neuronal excitability, and Ab. Loss of sleep leads to
neuronal hyperexcitation, which in turn increases Ab burden.
Ab expression both reduces sleep and further enhances
neuronal excitability (Figure 7F). Furthermore, suppression of
Ab-induced neuronal hyperexcitability significantly prolongs
lifespan, suggesting that abnormal neuronal activity is an
important mediator of Ab toxicity.
How are changes in sleep related to alterations in neuronal
excitability? In animals ranging from flies to humans, sleep is
associated with broad changes in patterns of electrical activity
[65, 66]. Although the function of sleep remains controversial,
one prominent hypothesis is that sleep functions to downscale
synaptic strength [15]. Along these lines, prolonged wakeful-
ness has been associated with an increase in evoked cortical
local field potential amplitudes in rats [16] and transcranial
magnetic stimulation (TMS) measures of cortical excitability
in humans [67]. Our data support this hypothesis, as sleep
deprivation in flies leads to hyperexcitability of l-LNv neurons.
Another recent study found that the ExFl2 neurons in
Drosophila also exhibited increased excitability with sleep
deprivation, although in that case, it was suggested that this
phenotype was related to the specific sleep-promoting func-
tion of those neurons [37].
There are a number of studies on the effects of APP or Ab
expression on neuronal activity in animal models of AD [49].
These studies, which have largely been conducted in mamma-
lian systems, have been conflicting, possibly because different
cell types and neuronal networks may behave differently in
response to exposure to Ab. Here, we have recorded from a
single cell type (the l-LNvs) from intact fly brains and found
that Ab expression markedly increases intrinsic neuronal
excitability and that this effect is exacerbated by sleep depri-
vation. Interestingly, patients with epilepsy exhibit elevated
amounts of Ab plaque in their brains [68]. Moreover, seizures
are commonly seen in patients with early-onset AD carrying
mutations in Presenilin 1 [69], and TMS studies have found
increased excitability of primary motor cortex in patients
with AD [70].
Our study suggests that neuronal hyperexcitability is an
important and early contributor to the pathogenesis of AD.Changes in neuronal excitability in AD likely predate neuro-
degenerative changes [71]. For example, in young mice over-
expressing APP, hippocampal neurons were found to be
hyperactive, prior to the formation of Ab plaques [50]. Further-
more, recent evidence suggests that increases in neuronal
excitability may be deleterious for cognitive function. Indeed,
patients with amnestic MCI exhibit increased hippocampal
activation by high-resolution fMRI, and reduction of this hippo-
campal activation with LEV improved memory performance
in these subjects [60]. Similar observations have been made
in a mouse model of AD and in aged rats with cognitive impair-
ment [61, 72]. We now provide evidence that reducing the
neuronal activity of Ab-expressing flies with LEV prolongs their
lifespan. Thus, taken together, these findings imply that early
treatment of preclinical AD patients with anti-epileptic medi-
cations may be beneficial in slowing the course of disease.
Our findings reveal an important interaction between Ab and
sleep loss in modulating neuronal excitability and suggest
that sleep loss, neuronal hyperexcitability, and Ab accumula-
tion form a positive feedback loop. As therapeutic interven-
tions exist to manipulate sleep as well as neuronal excitability,
these data suggest that targeting these pathways may be a
fruitful approach toward slowing the progression or delaying
the onset of this incurable disease.
Experimental Procedures
Details of experimental procedures are available in the online Supplemental
Information.
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